Currently, Jeff serves as the CEO at VS Health Group and is responsible for the development and execution of our corporate strategy.
In this role, Jeff leverages his extensive expertise of building great teams, in fast-growing companies, that are capable of developing into industry leaders.
Prior to joining VS Health Group, Jeff co-founded and managed Skysis, a best-in-class, pharma services consultancy that was sold to Avalere Health in 2020.
He also served as Chief Financial Officer at Medpace, where he played a pivotal role in executing a global strategy that achieved industry leading revenue growth and profitability, and which ultimately led to the sale of the company.
Jeff’s career also includes roles at Shire Pharmaceuticals where he was the Senior Vice President, Finance during a period of significant growth and expansion in the US; and at Arthur Andersen where he started his career.
Jeff’s focus at VS Health is to build the best team of market access experts in the US, who are capable of providing unique insights to clients, and are passionate about the quality of the work they deliver.
Jeff earned his BSBA from Xavier University.